Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Recycle-2-Earn App Ecoterra Adds Top Brands to Scannable Product Database in Boost for Presale

Thursday April 6th 2023 – Recycle-2-earn platform Ecoterra today announced it has the green light to start integrating the products of household-name brands Vittel, San Pellegrino, Heineken and Dr Pepper into its scannable database. It means consumers will be able to scan recyclable products from those brands, such as plastic bottles and aluminum cans. As a result, the Ecoterra app will be able to verify and record the items as recycled materials and reward the app user accordingly. Ecoterra’s mission is to incentivize consumers to boost their recycling efforts, and provide

Wärtsilä adds to its NACOS Platinum System with a new solution to ensure business continuity during software-related incidents

Wärtsilä Corporation, Trade Press Release, 6 April 2023 at 10.30 AM EESTTechnology group Wärtsilä has launched a new Fast Recovery tool that will ensure customers’ business continuity in the event of a software-related incident. The system will enable customers to reduce reputational and financial damages, minimise downtime, and recover the bridge and/or automation systems' direct and indirect costs. The tool will be made available as part of the NACOS Platinum System , which provides leading maritime bridge and

Sitowise Group Plc - Managers' Transactions - Haasmaa

Sitowise Group Plc                    Managers' transactions           6 April 2023 at 10.15 am EEST ____________________________________________ Person subject to the notification requirement Name: Heikki Hannu Antonio Haasmaa Position: Chief Executive Officer  Issuer: Sitowise Group Oyj LEI: 743700HOHMOHAANHFF73 Notification type: INITIAL NOTIFICATION Reference number: 28429/5/4 ____________________________________________ Transaction date: 2023-04-05 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI4000480215 Nature of transaction:

In 2022, the course was set for Viking Line’s sustainability far into the future

The placing in service of the new climate-smart Viking Glory and the sale of two old vessels were milestones in Viking Line’s sustainability work last year. EU regulations for vessel emissions are being tightened, and the company is showing the way to lower-emissions maritime transport for the entire sector. Viking Line’s sustainability measures in 2022 and views on the future of maritime transport have been compiled in a newly released sustainability report.In 2022, changes were made in Viking Line’s vessel fleet that will have a long-term impact on the company’s total emissions. The new

ZNN Bactiguard trauma nails get regulatory approvals in Japan

Since entering the initial license partnership with Zimmer Biomet, the ZNN Bactiguard trauma implants have been successfully launched across Europe, the Middle East and Africa. Today, Bactiguard announces that regulatory approvals have been obtained on the coated trauma implants in Japan, facilitating an upcoming commercial launch into the Japanese trauma market (valued at approximately USD 540 million according to GlobalData).Leading orthopedic company Zimmer Biomet and Bactiguard have been working together in partnership since 2019. The 2019 partnership gives Zimmer Biomet exclusivity to

Isofol Medical AB (publ) publishes annual report and corporate governance report for 2022

GOTHENBURG, Sweden, April 6, 2023 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), today announced that the company's annual report and corporate governance report for the financial year 2022 are now available, in Swedish, on the company's website, www.isofolmedical.com.The information in the press release is intended for investors. For further information, please contact Isofol Medical AB (publ)Thomas Andersson, Chief Executive Officer  E-mail: thomas.andersson@isofolmedical.comPhone: +46 (0) 709 44 00 93 Roy Jonebrant, Chief Financial Officer E-mail: roy.jonebrant@

Invitation to presentation of Balco Group’s first quarter report 2023

Balco Group’s interim report for the first quarter 2023 will be published at 13:00 CET on April 24, 2023. A webcast conference call will be held at 14:30 CET on the same day, where CEO and President Camilla Ekdahl and CFO Michael Grindborn will present the results for the first quarter of 2023.The presentation material will be available before the start of the conference call on the Balco Group website www.balcogroup.se. During the webcast there will be an opportunity to ask questions and follow the presentation material. It will also be possible to view the recorded version of the webcast

BioStock: Cyxone’s CEO comments on the US patent notice

Biotech company Cyxone develops new therapies for the treatment of autoimmune diseases, such as rheumatoid arthritis with the phase IIb candidate Rabeximod. The company reached a milestone in receiving a Notice of Allowance for the US patent of Rabeximod compounds. BioStock contacted CEO Carl-Magnus Högerkorp for a comment on the prospects of the patent.Read the interview with Cyxone's CEO Carl-Magnus Högerkorp at biostock.se: https://www.biostock.se/en/2023/04/cyxones-ceo-comments-on-the-us-patent-notice/ This is a press release from BioStock - Connecting Innovation & Capital. https:/

The Board of Directors of Inhalation Sciences resolves on a rights issue of approximately MSEK 17.1

The Board of Directors of Inhalation Sciences Sweden AB (publ) (”ISAB” or the ”Company”) has with the support of the authorization from the Annual General Meeting on May 6, 2022, resolved on a new issue of shares of approximately MSEK 17.1 with preferential rights for ISAB:s shareholders (the “Rights Issue”). The Company has received subscription- and guarantee commitments of approximately MSEK 13.7, which corresponds to approximately 80 percent of the Rights Issue. The purpose of the Rights Issue is to intensify the development of the Company’s contract research services. Furthermore, the

Easter greetings from our CEO

Dear Shareholders, Easter is coming shortly and soon it´s time to enjoy a couple of days off, creating new memories with family and friends and charging the batteries. This year, Easter time for me, also marks 6 months in the position as CEO of SpectrumOne. It has been an exciting journey and I am proud of what we as an organisation have achieved. Most importantly we have aligned as one organisation appreciating our most important assets being our engaged employees, our loyal customer and partner relations, and our strong and relevant service portfolio. Based on this we have

The exercise price for subscription of warrants of series TO3A and TO3B in Scandinavian ChemoTech AB has been set at SEK 4.79 per share, the exercise period begins April 11

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SOUTH AFRICA, SOUTH KOREA, OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES THAN SUCH MEASURES WHICH FOLLOWS FROM SWEDISH REGULATIONS. Scandinavian ChemoTech AB (“Scandinavian ChemoTech” or the “Company”) completed a rights issue of units in October 2022. Each (1) unit of series A consisted of one (1) newly issued

Invitation to the Volvo Group report on the first quarter 2023

The Volvo Group report for the first quarter 2023 will be published on April 20, 2023, at 7.20 a.m. CEST. There will be a conference call for press and analysts starting at 9.00 a.m. CEST.An online presentation of the report, followed by a question-and-answer session, will be broadcasted at 9.00 a.m. CEST. The Volvo Group will be represented by President and CEO Martin Lundstedt and acting CFO Jan Ytterberg. Link to webcast: https://volvo-qr.jawsapp.online/. Press and analysts who wants to participate in the press conference via conference call, may call the telephone exchange at +46

Intervacc publishes the 2022 Annual Report

Stockholm, April 6, 2023 - Intervacc AB (publ) announces that the company's 2022 Annual Report has been published today. The annual report (in Swedish) is attached and an English unaudited translation of the report is available for download on the company's website www.intervacc.com . For more information please contact:   Andreas Andersson, CEO Phone:  +46-8-120 10 601, cell +46-73-335 99 70E-mail: andreas.andersson@intervacc.com The information was submitted for publication, through the agency of the contact person set out above on

Wyld Networks receives SEK 4.3 million payment from UK Government for Research and Development (R&D)

Wyld Networks has received a cash payment of approximately SEK 4.3 million from UK Government for R&D activities. Research and development (R&D) tax credits are a UK government annual incentive designed to reward companies for investing in innovation.“We have invested significantly in R&D in our innovative satellite IoT solution,” said CFO of Wyld Networks, Christopher J. Caswell FCA. “This payment relates to our R&D activities in 2021 and we will submit our application this year to claim back up to 33% of the costs of our 2022 R&D activities.” For further information, please contact:

Audientes A/S – revised financial calender for 2023

Company announcement no. 09-20236 April, 2023   Audientes A/S (CVR 36047631) is announcing an update to its financial calender for 2023 related to the evaluation of different strategic alternatives for its capitalization and more longer-term structures related to strategic investments, partnerships and/or aquisition, as this may have significant bearing on the expectations and financial plan for the coming year.Background On 17 March, 2023, Audientes announced a revised financial calender for 2023 for, among others, the release of its Annual Report for 2022 and the upcoming

Lifco acquires Geax in Italy

Lifco  has signed an agreement to acquire a majority of the shares in the Italian company Geax srl. The company is a niche manufacturer of compact piling rigs.  In 2022, Geax reported net sales of approximately EUR 15 million. The company is based in Montefano, Italy and has 26 employees. Geax will be consolidated in Business Area Demolition & Tools. Consolidation is expected to take place in the second quarter of 2023. The acquisition will not have any significant effect on Lifco’s earnings or financial position in the current financial year.

Advenica receives an order worth MSEK 17.8 from a Swedish authority

Advenica has received a new order from a Swedish authority. The deal is worth MSEK 17.8 and is part of an agreement regarding deliveries of crypto products. In connection with this, the framework agreement between the parties has also been extended until 2025.Advenica is a well-established and trusted supplier of cybersecurity solutions both in Sweden and internationally. The solutions are based on Advenica's trusted technology and meet the authority's requirements for being able to communicate information that is classified up to Kvalificerat Hemlig. In addition, they are approved for

Oneflow’s monthly ARR update: March 2023

Press release6 April 2023 Oneflow publishes its preliminary monthly ARR. Oneflow had a total ARR (Annual Recurring Revenue) of MSEK 99.6 by the end of March 2023. This is a preliminary number. All financial reports and presentations are available for download on our website here: https://oneflow.com/ir/investors/financial-reports/ For further information, please contact: Anders Hamnes, CEO and FounderMobile: +46 76 788 50 76Email: anders.hamnes@oneflow.com About Oneflow Oneflow develops, sells, and implements digital contract management and automation systems.

Notice of annual shareholders’ meeting in Polygiene Group AB

The shareholders of Polygiene Group AB, Reg. No. 556692-4287, are hereby invited to attend the annual shareholders’ meeting to be held on Thursday 11 May 2023 at 13.00 p.m. at STUDIO, Nordenskiöldsgatan 24, in Malmö.Right to participate and notification Shareholders wishing to participate in the annual shareholders’ meeting must: · partly be listed in the company’s share register kept by Euroclear Sweden AB as of Wednesday 3 May 2023; and · partly have given a notice of their intent to participate to the company no later than on Friday 5 May 2023 by mail to Polygiene Group AB,

Invitation to presentation of the first quarter 2023 results

Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) will publish its first quarter 2023 results on Friday 21 April 2023. The presentation will be hosted by Kjell Johnsen, President and CEO, and Charlotte Hansson, EVP Group CFO.Tele2 will publish its financial results for the first quarter 2023 at 07:00 CEST (06:00 BST, 01:00 EDT) on Friday 21 April 2023.   Teleconference and webcastTele2 will host a teleconference and webcast with presentation at 10:00 CEST (09:00 BST, 04:00 EDT) on Friday 21 April 2023. The presentation will be held in English.   Registration

Notice of the Annual General Meeting of Fastighets AB Balder (publ)

The shareholders of Fastighets AB Balder (publ), corporate identity no. 556525–6905, (the ”Company”) are hereby notified of the Annual General Meeting (AGM) to be held on Thursday, May 11, 2023 at 4 p.m. CET, at Filmstaden Bergakungen, Skånegatan 16B, Gothenburg.The English text is an unauthorized translation solely for convenience purposes. In case of inconsistencies between the Swedish and the English text, the Swedish text shall prevail. Right to participate in the Annual General Meeting Shareholders wishing to participate in the AGM shall · be listed as shareholders (not

Herantis Pharma to participate in Nordic Health Summit Japan 2023

Herantis Pharma Plc, Press Release, 6 April 2023 at 09:00 A.M. EEST Herantis Pharma Plc (“Herantis”), developing disease-modifying therapies for Parkinson’s disease, today announced the participation in Nordic Health Summit Japan, April 25[th], 2023. About Nordic Health Summit Japan: The Nordic Health Summit Japan is a partnering and investor conference that connects Nordic healthcare innovations and Japanese investors and industry, organized by Business Sweden. If you want to learn more about Herantis and our asset HER-096, you can contact the conference organizers or connect

There are no items matching the current filter
There are no more items matching the current filter
Back to top